Is Canopy Growth Corporation a good investment? Canopy Growth Corporation (CGC) is currently trading at 1.00 USD.
Earnings Schedule: Canopy Growth Corporation is expected to release its next earnings report on June 15, 2026. The market consensus estimate for Forward EPS is -0.07.
No, it does not currently pay a dividend.
Canopy Growth Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be June 15, 2026. The company currently has a trailing EPS of -1.33.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 20, 2023 | 0.100000 |
Community Discussion